These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 20798216)
1. Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax. Thomas R; Davies C; Nunez A; Hibbs S; Flick-Smith H; Eastaugh L; Smither S; Gates A; Oyston P; Atkins T; Eley S J Med Microbiol; 2010 Dec; 59(Pt 12):1415-1427. PubMed ID: 20798216 [TBL] [Abstract][Full Text] [Related]
2. Particle-size dependent effects in the Balb/c murine model of inhalational melioidosis. Thomas RJ; Davies C; Nunez A; Hibbs S; Eastaugh L; Harding S; Jordan J; Barnes K; Oyston P; Eley S Front Cell Infect Microbiol; 2012; 2():101. PubMed ID: 22919690 [TBL] [Abstract][Full Text] [Related]
3. Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia. Gutting BW; Nichols TL; Channel SR; Gearhart JM; Andrews GA; Berger AE; Mackie RS; Watson BJ; Taft SC; Overheim KA; Sherwood RL Front Cell Infect Microbiol; 2012; 2():87. PubMed ID: 22919678 [TBL] [Abstract][Full Text] [Related]
4. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Zaucha GM; Pitt LM; Estep J; Ivins BE; Friedlander AM Arch Pathol Lab Med; 1998 Nov; 122(11):982-92. PubMed ID: 9822127 [TBL] [Abstract][Full Text] [Related]
5. Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. Heine HS; Bassett J; Miller L; Hartings JM; Ivins BE; Pitt ML; Fritz D; Norris SL; Byrne WR Antimicrob Agents Chemother; 2007 Apr; 51(4):1373-9. PubMed ID: 17296745 [TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model. Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469 [TBL] [Abstract][Full Text] [Related]
8. Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. Glomski IJ; Piris-Gimenez A; Huerre M; Mock M; Goossens PL PLoS Pathog; 2007 Jun; 3(6):e76. PubMed ID: 17542645 [TBL] [Abstract][Full Text] [Related]
9. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Pitt ML; Little SF; Ivins BE; Fellows P; Barth J; Hewetson J; Gibbs P; Dertzbaugh M; Friedlander AM Vaccine; 2001 Sep; 19(32):4768-73. PubMed ID: 11535328 [TBL] [Abstract][Full Text] [Related]
10. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
12. Bacillus anthracis has two independent bottlenecks that are dependent on the portal of entry in an intranasal model of inhalational infection. Lowe DE; Ernst SM; Zito C; Ya J; Glomski IJ Infect Immun; 2013 Dec; 81(12):4408-20. PubMed ID: 24042112 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318 [TBL] [Abstract][Full Text] [Related]